TickerFacts.

Company research / NEOG

NEOGEN CORP (NEOG)

Build a valuation ↗↓ Download CSV

CIK 0000711377 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated MI
  • Fiscal year ends May 31

For the year ended 2026-05-31, NEOGEN CORP reported revenue of $870.40M. Revenue fell 2.7% from the prior annual period.

Key ratios (year ended 2026-05-31)

46.9%
Gross margin
-2.5%
Operating margin
-0.9%
Net margin
-0.4%
Return on year-end equity
-2.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: DEF 14A · 2026-08-21

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2026-05-312025-05-312024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312017-05-31
Revenue$870.40M$894.70M$924.20M$822.45M$527.16M$468.46M$418.17M$414.19M$397.93M$358.28M
Cost of Revenue$461.90M$473.30M$460.30M$416.49M$284.15M$253.40M$221.89M$222.27M$211.66M$189.35M
Gross Profit$408.50M$421.40M$463.90M$405.95M$243.01M$215.06M$196.28M$191.92M$186.27M$168.92M
Operating Income-$21.60M-$1.06B$58.60M$37.52M$58.62M$74.17M$67.52M$68.09M$70.19M$64.94M
Net Income-$7.90M-$1.09B-$9.40M-$22.87M$48.31M$60.88M$59.48M$60.18M$63.15M$43.79M
EPS (Diluted)$-0.04$-5.03$-0.04$-0.12$0.45$0.57$0.56$0.57$1.21$0.86
Total Assets$3.35B$3.44B$4.55B$4.55B$992.93M$920.19M$797.18M$695.74M$618.01M$528.41M
Total Liabilities$1.25B$1.37B$1.40B$1.42B$105.56M$79.81M$72.00M$57.84M$57.83M$56.65M
Shareholders' Equity$2.09B$2.07B$3.14B$3.13B$887.37M$840.38M$725.18M$637.90M$560.17M$471.76M
Cash & Equivalents$185.50M$129.00M$170.61M$163.24M$44.47M$75.60M$66.27M$41.69M$83.07M$77.57M
Operating Cash Flow$83.20M$58.20M$35.30M$41.03M$68.04M$81.09M$85.88M$63.84M$69.13M$60.27M
Capital Expenditures$51.30M$104.60M$111.40M$65.76M$24.43M$26.71M$24.05M$14.66M$20.95M$14.58M
Shares Outstanding217.70M217.00M217.04M216.25M107.80M107.47M105.89M52.22M51.74M50.93M
Weighted Average Diluted Shares217.50M216.90M216.50M188.88M108.02M107.12M105.72M104.85M52.15M51.16M
EPS (Basic)$-0.04$-5.03$-0.04$-0.12$0.45$0.57$0.57$0.58$1.23$0.87